When KDIGO Meets Frailty: Rethinking Chronic Kidney Disease Targets in Adults Aged 80 Years and Older
American Journal of Nephrology · 23.03.2026 · 1-10
DOI: 10.1159/000551636 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Nephrology, online erschienen am 23.03.2026. Verfasst von Carmine Zoccali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy, carmine.zoccali@icloud.com. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background: Chronic kidney disease (CKD) is highly prevalent in very old adults and frequently coexists with frailty, multimorbidity, and limited life expectancy. In this population, the risk-benefit balance of standard KDIGO-style treatment targets for blood pressure, glycemic control, albuminuria, lipid management, anemia, and CKD-mineral and bone disorder is fundamentally altered. The clinical trials underpinning these recommendations enrolled few very old patients and virtually no frail octogenarians or nonagenarians, so the evidence base is poorly aligned with the realities of advanced age. Summary: This narrative review examines CKD progression in frail very old adults, with particular attention to frailty, geriatric syndromes, and competing risks of end-stage kidney disease and death. It then proposes a pragmatic framework to adapt KDIGO-style targets by incorporating frailty assessment, life expectancy, and patient goals of care into therapeutic decisions. For each major treatment domain, the discussion moves from abstract targets to clinically meaningful, individualized ranges, emphasizing treatment simplification, systematic deprescribing, and preservation of physical and cognitive function as primary outcomes. Key Messages: The review identifies urgent research priorities, including trials that intentionally enroll frail older adults, evaluations of deprescribing strategies, and studies comparing conservative kidney management with dialysis in this highly vulnerable and rapidly growing patient group.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy, carmine.zoccali@icloud.com.
- Renal Research Institute, New York, New York, USA, carmine.zoccali@icloud.com.
- Associazione Ipertensione Nefrologia Trapianto Renale (IPNET), Reggio Calabria, Italy, carmine.zoccali@icloud.com.
- Division of Nephrology, Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
- Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland.
- Associazione Ipertensione Nefrologia Trapianto Renale (IPNET), Reggio Calabria, Italy.
Zitieren
APA
Zoccali, C., Kanbay, M., Wiecek, A., & Mallamaci, F. (2026). When KDIGO Meets Frailty: Rethinking Chronic Kidney Disease Targets in Adults Aged 80 Years and Older. American Journal of Nephrology, 1-10. https://doi.org/10.1159/000551636
Vancouver
Zoccali C, Kanbay M, Wiecek A, Mallamaci F. When KDIGO Meets Frailty: Rethinking Chronic Kidney Disease Targets in Adults Aged 80 Years and Older. American Journal of Nephrology. 2026:1-10. doi:10.1159/000551636
BibTeX
@article{Zoccali2026,
author = {Zoccali, Carmine and Kanbay, Mehmet and Wiecek, Andrzej and Mallamaci, Francesca},
title = {When KDIGO Meets Frailty: Rethinking Chronic Kidney Disease Targets in Adults Aged 80 Years and Older},
journal = {American Journal of Nephrology},
year = {2026},
pages = {1--10},
doi = {10.1159/000551636}
}
EUVIMED